The Technical Advisory Group on SARS-CoV-2 Virus Evolution met today to review what is known about the #COVID19 variant B.1.1.529.
They advised WHO that it should be designated a Variant of Concern.
WHO has named it Omicron, in line with naming protocols bit.ly/3r8YrEd
The designation of Variant of Concern means:
🔴 countries should share genome sequences
🔴 report initial cases/clusters to WHO
🔴 perform field investigations & lab assessments to understand impacts, epidemiology, severity, effectiveness of public health & social measures
This new #COVID19 Variant of Concern Omicron underscores the need to accelerate #VaccinEquity and get COVID-19 vaccines to health workers, older people and others at risk who still have not received their first and second doses.
We should work together to reduce the circulation of #COVID19:
💉Get vaccinated if you have access
😷 Wear a mask
↔️ Keep physical distance
🪟 Ventilate spaces
🤧🧼 Good hand & respiratory hygiene
WHO & @FIFAcom are teaming up for the #SafeHome campaign to raise awareness about domestic violence & support those at risk, during the #16Days of Activism against Gender-Based Violence.
Across their lifetime, 1⃣ in 3⃣ 🙎♀️ aged 15 & over, ~736 million, are subjected to physical &/or sexual violence by an intimate partner or sexual violence from a non-partner - a number that has remained largely unchanged over the past decade.
If you are experiencing violence & need to leave in a hurry:
🏘️ Identify a friend, neighbour, relative or #SafeHome you can go to
🔀 Plan how to get there
🎒 Keep ready essential personal items to take with you
Countries should consider the individual & population benefits of immunising children and adolescents in their specific epidemiological and social context when developing their #COVID19 immunisation policies and programs bit.ly/32jwBur
As children & adolescents tend to have milder disease compared to adults, unless they are in a group at higher risk of severe #COVID19, it is less urgent to vaccinate them than older people, those with chronic health conditions & health workers bit.ly/32jwBur
@DrTedros "Last week, more than 60% of all reported cases and deaths from #COVID19 globally were once again in Europe. The sheer number of cases is translating to unsustainable pressure on health systems and exhausted #healthworkers"-@DrTedros
@DrTedros "In many countries and communities, we are concerned about a false sense of security that vaccines have ended the #COVID19 pandemic, and that people who are vaccinated do not need to take any other precautions"-@DrTedros
WHO & @MedsPatentPool announce the first transparent, global, non-exclusive licence for a #COVID19 technology, after finalizing a licensing agreement with @CSIC for a COVID-19 serological antibody technology.
The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to an infection or to a vaccine. This represents the first test licence signed by @MedsPatentPool & included in WHO’s #COVID19 Technology Access Pool
The aim of the licence is to facilitate the rapid manufacture and commercialization of @CSIC’s #COVID19 serological test worldwide. The agreement covers all related patents and the biological material necessary for manufacture of the test.
🆕 Updated guidelines on the management of multisystem inflammatory syndrome in children associated with #COVID19bit.ly/3l0vZQW
The updated guidelines recommend the use of corticosteroids in hospitalized children (aged 0-18 years) with this condition, in addition to supportive treatment and care bit.ly/3l0vZQW
Multisystem inflammatory syndrome is a rare but serious condition where children with #COVID19 develop inflammation affecting different organs of the body bit.ly/3l0vZQW
Those rebuilding their lives after road traffic crashes and their families deserve appropriate medical, psychological, legal, and financial support. bit.ly/3HuLScd